Skip to content

NXTC · NextCure, Inc.

Healthcare · −9.3% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 8 feeds behind: FDA drug approvals, 4 days, and 7 more · Every feed →

On this page

The market view

Price chart

The interactive NXTC chart (by TradingView) loads here.

Our take

3 rules fired on NXTC

In short: none of these rules has solid or some evidence yet, so they show no clear lean on NXTC.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for NXTC, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on NXTC, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of NXTC. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 23, 2026–Oct 20, 2026 · UTC dates · today is excluded

Insider purchases

Short history

Only 2 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
0
Earlier median
1
Earlier range
0–2
Distinct filers per 28 daysScale: 0–2
Oct 22, 2025Oct 20, 2026
Earlier periodsLatest 28 daysEarlier median 1Limited or missing history

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jul 29, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 2. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 2 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 1; range: 0–2.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 20262Within stored history
Aug 26, 2026–Sep 22, 20260Within stored history
Sep 23, 2026–Oct 20, 2026Latest period0Within stored history
Insider sales · Short history

Only 2 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 3; range: 0–6.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 20266Within stored history
Aug 26, 2026–Sep 22, 20260Within stored history
Sep 23, 2026–Oct 20, 2026Latest period0Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 2026—Unavailable
Aug 26, 2026–Sep 22, 2026—Unavailable
Sep 23, 2026–Oct 20, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 2026—Unavailable
Aug 26, 2026–Sep 22, 2026—Unavailable
Sep 23, 2026–Oct 20, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

FDA & trials

Owners & lobbying

All 36 records in this snapshot
  1. Filed
  2. Filed
  3. Filed
  4. Filed
  5. Filed
  6. Record date
  7. Filed
  8. Disclosed
  9. Disclosed
    Jinsheng Ren · Sale

    Transaction dated Aug 10, 2026

  10. Disclosed
    Renhong Tang · Sale

    Transaction dated Aug 10, 2026

  11. Disclosed
    Simcere Pharmaceutical Group Ltd · Sale

    Transaction dated Aug 10, 2026

  12. Disclosed
  13. Disclosed
    Simcere Zaiming, Inc. · Sale

    Transaction dated Aug 10, 2026

  14. Disclosed
    ADAR1 Capital Management, LLC · Purchase

    Transaction dated Jul 30, 2026

  15. Disclosed
    ADAR1 Capital Management, LLC · Purchase

    Transaction dated Jul 30, 2026

  16. Disclosed
    ADAR1 Capital Management, LLC · Purchase

    Transaction dated Jul 31, 2026

  17. Disclosed
    ADAR1 Capital Management, LLC · Purchase

    Transaction dated Jul 30, 2026

  18. Disclosed
    ADAR1 Capital Management, LLC · Purchase

    Transaction dated Jul 30, 2026

  19. Disclosed
    ADAR1 Capital Management, LLC · Purchase

    Transaction dated Jul 31, 2026

  20. Disclosed
    ADAR1 Capital Management, LLC · Purchase

    Transaction dated Jul 31, 2026

  21. Disclosed
    ADAR1 Capital Management, LLC · Purchase

    Transaction dated Jul 30, 2026

  22. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 30, 2026

  23. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 30, 2026

  24. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 30, 2026

  25. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 31, 2026

  26. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 31, 2026

  27. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 31, 2026

  28. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 30, 2026

  29. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 30, 2026

  30. Disclosed
    ADAR1 Capital Management, LLC · Purchase

    Transaction dated Jul 27, 2026

  31. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 27, 2026

  32. Disclosed
    Daniel Schneeberger · Purchase

    Transaction dated Jul 29, 2026

  33. Record date
    FDA clinical hold ↗

    8-K · mentioned before

  34. Record date
    FDA warning letter ↗

    8-K · mentioned before

  35. Record date
  36. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on NXTC disclosed in the last 90 days.

See every Congress trade on NXTC →

Company insiders

4 buys · 6 sells (30 filed lots) · $1.1M sold · $3.2M bought

  1. ▼ SELLRenhong Tang InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  2. ▼ SELLSimcere Zaiming, Inc. InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  3. ▼ SELLSimcere Zaiming Pharmaceutical Co., Ltd. InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  4. ▼ SELLJiangsu Simcere Zaiming Pharmaceutical Co., Ltd. InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  5. ▼ SELLJinsheng Ren InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  6. ▼ SELLSimcere Pharmaceutical Group Ltd InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  7. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$386Kdisclosed Aug 3 · filed 4 days after the trade
  8. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$249Kdisclosed Aug 3 · filed 4 days after the trade
  9. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$120Kdisclosed Aug 3 · filed 4 days after the trade
  10. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$490Kdisclosed Aug 3 · filed 4 days after the trade
See every insider trade on NXTC →

Big holders (Schedule 13D / 13G): 2 filings in the last 90 days · newest: ADAR1 Capital Management, LLC (13G), Aug 14, 2026 ↗

Filings & events

Company filings (8-K) 66

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Quarterly or yearly results · item 2.0210
  • Other events · item 8.018
  • Shared information with investors · item 7.017
  • Directors or officers joined, left or got new pay · item 5.025
  • Signed a major agreement · item 1.014
  • Shareholder vote results · item 5.074

Filing red flags 15

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

5% owners (13D / 13G) 8

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 1 filing
  • 13G, just holds: 7 filings

Filed by ADAR1 Capital Management, LLC · Adage Capital Management, L.P. · Sofinnova Venture Partners IX, L.P. · Ikarian Capital, LLC

Biggest named funds (13F)

The largest NXTC holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on NXTC

  1. ▼ SELLRenhong Tang InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  2. ▼ SELLSimcere Zaiming, Inc. InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  3. ▼ SELLSimcere Zaiming Pharmaceutical Co., Ltd. InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  4. ▼ SELLJiangsu Simcere Zaiming Pharmaceutical Co., Ltd. InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  5. ▼ SELLJinsheng Ren InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  6. ▼ SELLSimcere Pharmaceutical Group Ltd InsiderNXTC NextCure, Inc.$185Kdisclosed Aug 12 · filed 2 days after the trade
  7. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$386Kdisclosed Aug 3 · filed 4 days after the trade
  8. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$249Kdisclosed Aug 3 · filed 4 days after the trade
  9. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$120Kdisclosed Aug 3 · filed 4 days after the trade
  10. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$490Kdisclosed Aug 3 · filed 4 days after the trade
  11. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$125Kdisclosed Aug 3 · filed 3 days after the trade
  12. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$490Kdisclosed Aug 3 · filed 4 days after the trade
  13. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$16.4Kdisclosed Aug 3 · filed 3 days after the trade
  14. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$38.4Kdisclosed Aug 3 · filed 3 days after the trade
  15. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$38.4Kdisclosed Aug 3 · filed 3 days after the trade
  16. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$100Kdisclosed Aug 3 · filed 4 days after the trade
  17. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$120Kdisclosed Aug 3 · filed 4 days after the trade
  18. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$125Kdisclosed Aug 3 · filed 3 days after the trade
  19. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$249Kdisclosed Aug 3 · filed 4 days after the trade
  20. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$16.4Kdisclosed Aug 3 · filed 3 days after the trade
  21. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$386Kdisclosed Aug 3 · filed 4 days after the trade
  22. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$100Kdisclosed Aug 3 · filed 4 days after the trade
  23. ▲ BUYADAR1 Capital Management, LLC 10% ownerNXTC NextCure, Inc.$39Kdisclosed Jul 29 · filed 2 days after the trade
  24. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$39Kdisclosed Jul 29 · filed 2 days after the trade
  25. ▲ BUYDaniel Schneeberger 10% ownerNXTC NextCure, Inc.$8Kdisclosed Jul 29 · filed the same day
See all 30 trades on NXTC →
People & votes

Which members of Congress traded NXTC, sponsored bills that touch it and voted on them — opens here.